Only two targets (VEGF-A: P < 0.001 and DNMT3A: P = 0.039) among the 41 genes exhibited significantly higher gene expression in the Brain meta than Primary breast cancers group (Fig. 3). This evidence concerns the gene DNMT3A and breast cancer.